Models of agonist-antagonist interaction [proceedings]. 1976

D W Vere

UI MeSH Term Description Entries
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D004336 Drug Antagonism Phenomena and pharmaceutics of compounds that inhibit the function of agonists (DRUG AGONISM) and inverse agonists (DRUG INVERSE AGONISM) for a specific receptor. On their own, antagonists produce no effect by themselves to a receptor, and are said to have neither intrinsic activity nor efficacy. Antagonism, Drug,Antagonisms, Drug,Drug Antagonisms
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug

Related Publications

D W Vere
January 1981, Psychopharmacology bulletin,
D W Vere
January 2018, Central nervous system agents in medicinal chemistry,
D W Vere
February 1972, The Australian journal of experimental biology and medical science,
D W Vere
January 1984, Progress in neuro-psychopharmacology & biological psychiatry,
D W Vere
January 1976, Annals of the New York Academy of Sciences,
D W Vere
October 1995, Journal of veterinary pharmacology and therapeutics,
D W Vere
July 2005, Biochemical and biophysical research communications,
Copied contents to your clipboard!